Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma

被引:24
|
作者
Choi, J. W. [1 ]
Lee, D. [2 ]
Hyun, S. H. [3 ]
Han, M. [1 ]
Kim, J. -H. [2 ]
Lee, S. J. [4 ]
机构
[1] Ajou Univ, Sch Med, Dept Radiol, Suwon, South Korea
[2] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea
[4] Ajou Univ, Sch Med, Dept Nucl Med, 164 Worldcup Ro, Suwon 16499, South Korea
基金
新加坡国家研究基金会;
关键词
APPARENT DIFFUSION-COEFFICIENT; F-18-FDG UPTAKE; INVASIVE COMPONENTS; SURVIVAL; CANCER; PARAMETERS; PREDICTOR;
D O I
10.1016/j.crad.2017.01.019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To evaluate the association between the tumourestroma ratio and intratumoural heterogeneity measured using 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography (PET) and magnetic resonance imaging (MRI), and further investigate the prognostic significance of imaging biomarkers in head and neck squamous cell carcinoma (HNSCC). MATERIALS AND METHODS: Textural-based imaging parameters of the primary tumour were extracted in 44 patients. In addition, the difference between the minimum and maximum apparent diffusion coefficient (ADC) values (ADCdiff) was calculated on MRI. The relationships between the tumourestroma ratio and imaging parameters were evaluated. The associations between imaging parameters and recurrence-free survival (RFS) were assessed using Cox proportional hazard regression models. RESULTS: Coarseness (r = -0.382) on PET and ADCdiff (r = 0.534) on MRI were significantly correlated with the proportion of stroma. The best imaging biomarkers for the 2-year RFS prediction were coarseness (AUC = 0.741) and ADCdiff (AUC = 0.779). Multivariate analysis showed that coarseness (hazard ratio = 10.549, 95% confidence interval = 2.544-43.748, p = 0.001) was an independent prognostic factor for RFS. CONCLUSION: Heterogeneity imaging parameters are significantly associated with the tumourestroma ratio. These imaging biomarkers may help to facilitate the risk stratification for tumour recurrence in HNSCC. (C) 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:482 / 489
页数:8
相关论文
共 50 条
  • [21] Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review
    de Morais, Everton Freitas
    de Farias Morais, Hannah Gil
    Dantas Martins, Helder Domiciano
    Carlan, Leonardo Magalhaes
    Lopes Costa, Antonio de Lisboa
    Freitas, Roseana de Almeida
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2022, 27 (04): : e301 - e309
  • [22] 18F-FDG-PET/CT for the Assessment of the Contralateral Neck in Patients with Head and Neck Squamous Cell Carcinoma
    Kastrinidis, Nikos
    Kuhn, Felix P.
    Hany, Thomas F.
    Ahmad, Nader
    Huber, Gerhard F.
    Haerle, Stephan K.
    LARYNGOSCOPE, 2013, 123 (05) : 1210 - 1215
  • [23] Role of 18F-FDG PET-CT in head and neck squamous cell carcinoma
    Castaldi, P.
    Leccisotti, L.
    Bussu, F.
    Micciche, F.
    Rufini, V.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2013, 33 (01) : 1 - 8
  • [24] Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression
    Parajuli, Himalaya
    Teh, Muy-Teck
    Abrahamsen, Siren
    Christoffersen, Ingrid
    Neppelberg, Evelyn
    Lybak, Stein
    Osman, Tarig
    Johannessen, Anne Chr
    Gullberg, Donald
    Skarstein, Kathrine
    Costea, Daniela Elena
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (04) : 267 - 275
  • [25] Baseline Neutrophil-to-Lymphocyte Ratio and Glasgow Prognostic Score are Associated with Clinical Outcome in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
    Chikuie, Nobuyuki
    Hamamoto, Takao
    Ueda, Tsutomu
    Taruya, Takayuki
    Kono, Takashi
    Furuie, Hiromi
    Ishino, Takashi
    Takeno, Sachio
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 335 - 343
  • [26] Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis
    Jin, Aihua
    Lin, Xing
    Yin, Xuezhe
    Cui, Yinfeng
    Ma, Liguang
    MEDICINE, 2022, 101 (39) : E30798
  • [27] Early Response Prediction of Multiparametric Functional MRI and 18F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation
    Martens, Roland M.
    Koopman, Thomas
    Lavini, Cristina
    van de Brug, Tim
    Zwezerijnen, Gerben J. C.
    Marcus, J. Tim
    Vergeer, Marije R.
    Leemans, C. Rene
    de Bree, Remco
    de Graaf, Pim
    Boellaard, Ronald
    Castelijns, Jonas A.
    CANCERS, 2022, 14 (01)
  • [28] High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma
    Mroz, Edmund A.
    Tward, Aaron D.
    Pickering, Curtis R.
    Myers, Jeffrey N.
    Ferris, Robert L.
    Rocco, James W.
    CANCER, 2013, 119 (16) : 3034 - 3042
  • [29] Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma
    Fujima, Noriyuki
    Andreu-Arasa, V. Carlota
    Meibom, Sara K.
    Mercier, Gustavo A.
    Salama, Andrew R.
    Minh Tam Truong
    Sakai, Osamu
    EUROPEAN RADIOLOGY, 2020, 30 (11) : 6322 - 6330
  • [30] Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma
    Guezennec, Catherine
    Robin, Philippe
    Orlhac, Fanny
    Bourhis, David
    Delcroix, Olivier
    Gobel, Yves
    Rousset, Jean
    Schick, Ulrike
    Salaun, Pierre-Yves
    Abgral, Ronan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (02): : 495 - 502